Centr Brands Stock Price, News & Analysis
Company Description
Centr Brands (OTC Link: CNTRF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $176.0K.
CNTRF stock has declined 57.1% over the past year. Shares last traded at $0.0120.
This page provides a comprehensive overview of CNTRF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Centr Brands (CNTRF) stock last traded at $0.0120. Over the past 12 months, the stock has lost 57.1%. At a market capitalization of $176.0K, CNTRF is classified as a micro-cap stock with approximately 11.6M shares outstanding.
Latest News
Centr Brands has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 1 with negative movement. Key topics include management. View all CNTRF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Centr Brands (CNTRF) currently stands at 265 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 11.7%. This relatively low short interest suggests limited bearish sentiment. The 9.8 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Centr Brands (CNTRF) currently stands at 9.8 days, down 55.6% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 96.2% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
CNTRF Company Profile & Sector Positioning
Centr Brands (CNTRF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CNTRF often look at related companies in the same sector, including Xebra Brands (XBRAF), Canntab Therapeutics Ltd (CTABF), Pineapple Express Cannabis Co (PNXP), Golden Developin (DVLP), and Noveris Health Sciences Inc (MYCOF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CNTRF's relative position within its industry.